Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1394
https://www.valueinhealthjournal.com/article/S1098-3015(16)32760-7/fulltext
Title :
Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32760-7&doi=10.1016/j.jval.2016.09.1394
First page :
A589
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1316